Vilacto Bio (Vilacto Bio) Interest Expense : $-1.31 Mil (TTM As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vilacto Bio's interest expense for the three months ended in Jun. 2019 was $ -0.27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2019 was $-1.31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vilacto Bio's Operating Income for the three months ended in Jun. 2019 was $ -0.15 Mil. Vilacto Bio's Interest Expense for the three months ended in Jun. 2019 was $ -0.27 Mil. Vilacto Bio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vilacto Bio Interest Expense Historical Data

The historical data trend for Vilacto Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Interest Expense Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Interest Expense

Get a 7-Day Free Trial

-0.04

-1.13

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
Interest Expense	Get a 7-Day Free Trial															-0.10	-0.26	-0.37	-0.41	-0.27

Vilacto Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.31 Mil.

Vilacto Bio (GREY:VIBI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vilacto Bio's Interest Expense for the three months ended in Jun. 2019 was $-0.27 Mil. Its Operating Income for the three months ended in Jun. 2019 was $-0.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2019 was $0.00 Mil.

Vilacto Bio's Interest Coverage for the quarter that ended in Jun. 2019 is calculated as

Vilacto Bio did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.